Olopatadine Hydrochloride
Brand Names: Pataday Once Daily Relief, Eye Allergy Itch and Redness Relief, Olopatadine HCl, Retaine Allergy, Patanase
Methodology & AI Transparency ⓘ
Olopatadine Hydrochloride Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Olopatadine hydrochloride nasal solution (nasal spray) is indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 years of age and older.
- 2 Real-world patient consensus: 89% patient "Worth It" rating across 18 anonymous logs for Olopatadine Hydrochloride (RxNorm 1797895).
- 3 Typical cash cost range: 30-day cash pricing ranges from $9.89 on Cost Plus Drugs to $34.50 walk-in retail (NADAC $5.7473/unit).
- 4 Top reported side effects / signs: Key post-marketing and trial adverse reactions (Olopatadine Hydrochloride): headache (11.2%), somnolence (7.6%), cutaneous rash (4.5%).
Ask our AI Specialists anything about Olopatadine Hydrochloride
Olopatadine Hydrochloride Mechanism, CYP450 Pathways & DailyMed Monograph
Olopatadine hydrochloride nasal solution (nasal spray) is indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 years of age and older. Olopatadine hydrochloride nasal solution (nasal spray) is an H 1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 years of age and older.
12.1 Mechanism of Action Olopatadine is a histamine H 1 receptor antagonist. The antihistaminic activity of olopatadine has been documented in isolated tissues, animal models, and humans.
Following administration (2 mg/mL Solution), Olopatadine Hydrochloride achieves Estimated 67%–79% oral systemic absorption for Olopatadine Hydrochloride bioavailability and peak plasma tmax within 30 minutes (olopatadine hydrochloride) onset, governed by a Approximately 3–9 hours terminal plasma half-life for Olopatadine Hydrochloride terminal half-life through phase i/ii hepatic conjugation of olopatadine hydrochloride coupled with glomerular and tubular renal excretion.
Before initiating Olopatadine Hydrochloride at 2 mg/mL Solution, clinical safety checklists rule out prior anaphylaxis, angioedema, or severe hypersensitivity to olopatadine hydrochloride or olopatadine hydrochloride excipients; co-administration with prohibited interacting drugs or decompensated organ failure per 2024-05-10 olopatadine hydrochloride spl. Logged tolerability patterns center on headache (11.2% of reports), nausea (8.5% of reports), somnolence (7.6% of reports).
Avoid overlapping histamine-1 receptor antagonist prescriptions alongside Olopatadine Hydrochloride to prevent cumulative receptor toxicity.
Alcohol or high-fat meal timing can shift absorption rate and orthostatic tolerance during Olopatadine Hydrochloride dosing.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Prior anaphylaxis, angioedema, or severe hypersensitivity to Olopatadine Hydrochloride or Olopatadine Hydrochloride excipients
- Co-administration with prohibited interacting drugs or decompensated organ failure per 2024-05-10 Olopatadine Hydrochloride SPL
Logged Side-Effect Incidence (18 Reports)
Olopatadine Hydrochloride Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Olopatadine Hydrochloride)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Results : 263 Japanese subjects were enrolled; 224 completed the trial. Ocular immunology and inflammation • 2021-11-17 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 32501774 ↗ |
| Can This Approach Help? Inside the Latest Research on Olopatadine, a non-sedating H1 antihistamine, decreases the nocturnal scratching We have demonstrated for the first time that a second-generation antihistamine ameliorates nocturnal scratching behavior in eczema patients using a modified wristwatch-type acoustic scratching counting system that we have... Experimental dermatology • 2015-03-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 25641045 ↗ |
Olopatadine Hydrochloride Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $5.7473/unit (~$172.42/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $9.89 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 18 Anonymous DotMD Community Micro-Logs | $11.37 / mo | View logs ↓ |
Olopatadine Hydrochloride Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Olopatadine Hydrochloride RxNorm Concept ID | 1797895 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $5.7473 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $9.89 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 89.00% Worth It (18 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Olopatadine Hydrochloride Patient Community, Cohort Filters & Dosage Logs
Evidence synthesis for Olopatadine Hydrochloride: FDA labeling (2024-05-10, NDC 0065-8150), CYP/interaction screening, and public pharmacy acquisition costs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Olopatadine Hydrochloride community threads and patient logs by age, biological sex, dosage, and treatment duration.